Overview

Bioequivalence Study Comparing Mucinex Extended-release 600 mg Tablets to Immediate-release Guaifenesin 600 mg in Healthy Volunteers

Status:
Completed

Trial end date:
2009-02-01

Target enrollment:

Participant gender:

Summary

Determine bioequivalence, safety and tolerability of guaifenesin extended-release 600 mg (Mucinex® SE) compared to an immediate-release syrup reference product in normal healthy subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Reckitt Benckiser Inc.

Treatments:

Chlorpheniramine, phenylpropanolamine drug combination
Guaifenesin
Phenylpropanolamine